HU9802439D0 - An o-benzyloxy-carbonyl derivative of azythromycin a and its acid addition salts - Google Patents

An o-benzyloxy-carbonyl derivative of azythromycin a and its acid addition salts

Info

Publication number
HU9802439D0
HU9802439D0 HU9802439A HU9802439A HU9802439D0 HU 9802439 D0 HU9802439 D0 HU 9802439D0 HU 9802439 A HU9802439 A HU 9802439A HU 9802439 A HU9802439 A HU 9802439A HU 9802439 D0 HU9802439 D0 HU 9802439D0
Authority
HU
Hungary
Prior art keywords
azythromycin
benzyloxy
acid addition
addition salts
carbonyl derivative
Prior art date
Application number
HU9802439A
Other languages
English (en)
Other versions
HU221803B1 (hu
Inventor
Slobodan Djokic
Gabriela Kobrehel
Gorjana Lazarevski
Original Assignee
Pliva Pharm & Chem Works
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works
Publication of HU9802439D0 publication Critical patent/HU9802439D0/hu
Publication of HU221803B1 publication Critical patent/HU221803B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU9802439A 1990-07-18 1991-07-18 Azitromicin A O-benziloxi-karbonil-származék és savaddíciós sói HU221803B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU140990 1990-07-18
HU9202619A HU215158B (hu) 1990-07-18 1991-07-18 Eljárás egy azitromicin A O-benziloxi-karbonil-származék előállítására

Publications (2)

Publication Number Publication Date
HU9802439D0 true HU9802439D0 (en) 1998-12-28
HU221803B1 HU221803B1 (hu) 2003-01-28

Family

ID=25554060

Family Applications (4)

Application Number Title Priority Date Filing Date
HU912408A HUT59935A (en) 1990-07-18 1991-07-18 Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active components
HU9802439A HU221803B1 (hu) 1990-07-18 1991-07-18 Azitromicin A O-benziloxi-karbonil-származék és savaddíciós sói
HU9202619A HU215158B (hu) 1990-07-18 1991-07-18 Eljárás egy azitromicin A O-benziloxi-karbonil-származék előállítására
HU95P/P00748P HU211659A9 (en) 1990-07-18 1995-07-03 O-methyl derivatives of azithromycin a

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU912408A HUT59935A (en) 1990-07-18 1991-07-18 Process for producing o-methyl-derivatives of azitormycin a and pharmaceutical compositions containing them as active components

Family Applications After (2)

Application Number Title Priority Date Filing Date
HU9202619A HU215158B (hu) 1990-07-18 1991-07-18 Eljárás egy azitromicin A O-benziloxi-karbonil-származék előállítására
HU95P/P00748P HU211659A9 (en) 1990-07-18 1995-07-03 O-methyl derivatives of azithromycin a

Country Status (20)

Country Link
US (1) US5250518A (hu)
EP (1) EP0467331B1 (hu)
JP (1) JP2657132B2 (hu)
CN (1) CN1029738C (hu)
AT (1) ATE129715T1 (hu)
BG (1) BG60593B1 (hu)
CA (1) CA2046956C (hu)
CZ (1) CZ280640B6 (hu)
DE (1) DE69114198T2 (hu)
DK (1) DK0467331T3 (hu)
ES (1) ES2081397T3 (hu)
GR (1) GR3018330T3 (hu)
HR (1) HRP920491B1 (hu)
HU (4) HUT59935A (hu)
PL (1) PL166379B1 (hu)
RO (1) RO109338B1 (hu)
RU (1) RU2045533C1 (hu)
SI (1) SI9011409A (hu)
SK (1) SK279075B6 (hu)
UA (1) UA27105A1 (hu)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
PT1437359E (pt) * 1997-10-16 2007-04-30 Glaxosmithkline Zagreb Novos 3,6-hemicetais da classe dos 9a-azalidos
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
HRP980646B1 (en) * 1998-12-30 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Novel oleandomycin derivatives
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
EP1482957A4 (en) 2002-02-15 2006-07-19 Merckle Gmbh ANTIBIOTIC CONJUGATES
US20040005641A1 (en) 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CA2476423A1 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
WO2004106353A1 (en) * 2003-05-30 2004-12-09 Pliva - Istrazivacki Institut D.O.O. Process for selective alkylation of macrolide and azalide derivatives
US7435805B2 (en) * 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
WO2005021567A1 (en) * 2003-09-02 2005-03-10 Pliva - Istrazivacki Institut D.O.O. O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
KR20070105993A (ko) * 2005-01-13 2007-10-31 글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오. 소염 활성을 갖는 마크로라이드
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
WO2010086350A1 (en) 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases
TW201038277A (en) * 2009-01-30 2010-11-01 Glaxosmithkline Zagreb Anti-inflammatory macrolide
CN101830949B (zh) * 2009-03-13 2012-05-23 上海医药工业研究院 一种阿奇霉素衍生物、其中间体及其制备方法和应用
WO2011131749A1 (en) 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
CN102952166A (zh) * 2011-08-28 2013-03-06 山东方明药业集团股份有限公司 聚合物支载硼氢阴离子还原剂合成阿奇霉素中间体的方法
AU2013239679A1 (en) 2012-03-27 2014-10-30 Michael W. BURNET Anti-inflammatory macrolides
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
US11427606B2 (en) 2017-04-20 2022-08-30 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
JP2020517748A (ja) * 2017-04-20 2020-06-18 ライジング タイド ファウンデーション 抗がん剤としてホスホニウムイオンを含むアジスロマイシン誘導体
CA3060510A1 (en) 2017-04-21 2018-10-25 Lunella Biotech, Inc. Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs)
WO2018195446A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
PE20200605A1 (es) 2017-05-19 2020-03-10 Lunella Biotech Inc Antimitoscinas: inhibidores especificos de la biogenesis mitocondrial para erradicar celulas madre cancerosas
US12006553B2 (en) 2017-05-19 2024-06-11 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
CU20190106A7 (es) 2017-06-26 2020-11-30 Lunella Biotech Inc Mitocetoscinas: agentes terapéuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en células cancerosas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents

Also Published As

Publication number Publication date
ATE129715T1 (de) 1995-11-15
BG94837A (bg) 1993-12-24
EP0467331B1 (en) 1995-11-02
CS219591A3 (en) 1992-03-18
PL166379B1 (en) 1995-05-31
DK0467331T3 (da) 1996-02-05
BG60593B1 (bg) 1995-09-29
HU221803B1 (hu) 2003-01-28
US5250518A (en) 1993-10-05
DE69114198T2 (de) 1996-06-27
CZ280640B6 (cs) 1996-03-13
UA27105A1 (uk) 2000-02-28
CA2046956C (en) 1999-01-05
SK279075B6 (sk) 1998-06-03
HU912408D0 (en) 1991-12-30
HU211659A9 (en) 1995-12-28
GR3018330T3 (en) 1996-03-31
HUT62307A (en) 1993-04-28
HUT59935A (en) 1992-07-28
HU9202619D0 (en) 1992-12-28
PL291130A1 (en) 1992-11-16
CN1059728A (zh) 1992-03-25
CN1029738C (zh) 1995-09-13
JPH05132497A (ja) 1993-05-28
SI9011409A (en) 1995-10-31
HU215158B (hu) 1998-12-28
EP0467331A1 (en) 1992-01-22
HRP920491B1 (en) 1998-10-31
ES2081397T3 (es) 1996-03-01
HRP920491A2 (en) 1994-08-31
RU2045533C1 (ru) 1995-10-10
RO109338B1 (ro) 1995-01-30
CA2046956A1 (en) 1992-01-19
DE69114198D1 (de) 1995-12-07
JP2657132B2 (ja) 1997-09-24

Similar Documents

Publication Publication Date Title
HU9802439D0 (en) An o-benzyloxy-carbonyl derivative of azythromycin a and its acid addition salts
ZA892474B (en) Process for preparing derivatives of baccatine iii and of 10-deacetyl baccatine iii
TW341573B (en) New erythromycin derivatives, their preparation process and their use as medicaments
KR870007163A (ko) 질소함유 융합 헤테로 사이클릭 화합물의 제조방법
UA35592C2 (uk) Похідні оцтової кислоти
IE791189L (en) Benzomorphans
NO890567D0 (no) Anthracyklin-derivater.
DE3371205D1 (en) Aminonaphthacene derivatives and their production
ATE15047T1 (de) Galactopyranoside verbindungen, verfahren zu ihrer herstellung und ihre verwendung als antigene oder immunadsorbentien.
DE3770359D1 (de) 6-amino-anthracycline, verfahren zu ihrer herstellung und ihre verwendung.
ES8607935A1 (es) Un procedimiento de preparar un derivado de ariltio-piridi- nil-alcanol
ES2092962A1 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino) fenilacetoxiacetico y sus procedimientos de preparacion.
DK316589A (da) Substituerede azacyclohexylderivater af rifamyciner
ES478786A1 (es) Procedimiento para la obtencion de pigmentos de azometina.
DE68924010D1 (de) Verfahren zur Herstellung von 1-alpha,3-beta,24-Trihydroxy-delta-5-Steroidderivaten.
HUT65533A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical preparations containing them
IT1251158B (it) 13-diidro-3'-(2-alcossi-4-morfolinil)antracicline
PT98389A (pt) Processo de preparacao de derivados de estreptogramina
TR199901956T2 (xx) 4H-4-Okso-kinolizin-3-karboksilik asit t�revlerinin haz�rlanmas� i�in bir i�lem.
DE3372963D1 (en) Novel aminonaphthacene derivatives and process for preparation thereof
IT1214534B (it) 4-cloro-arilossi-acetil-e 4-cloro-arilossi-propionil-malonati aventi proprieta' erbicide.
GR1000821B (el) Μεθοδος παραγωγης παραγωγων κιναζολινονης.
ES8107249A1 (es) Un procedimiento para la preparacion de derivados de 2-epi- fortimicina.
MY101624A (en) Novel compounds and prosesses.
TW358087B (en) Method for preparing carbamoylmethylurea derivatives

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20021107

MM4A Lapse of definitive patent protection due to non-payment of fees